Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.46 |
| ▸ | ABAT | P80404 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL467699 | 1.00 | ESR1 (0.46) | ESR1ESR2ABATCA2CTBP2 | |
| SCHEMBL467700 | 1.00 | ESR1 (0.46) | ESR1ESR2ABATCA2CTBP2 | |
| SCHEMBL25620242 | 0.83 | ESR1 (0.48) | ESR1ESR2ABATCA2KDM4E | |
| SCHEMBL448421 | 0.79 | ESR1 (0.55) | ESR1ESR2ABATCA2KDM4E | |
| SCHEMBL448422 | 0.79 | ESR1 (0.55) | ESR1ESR2ABATCA2KDM4E | |
| SCHEMBL5898755 | 0.79 | IDO1 (0.45) | CTBP2ALDH1A1IDO1CYP2C19HTR3A | |
| SCHEMBL4618746 | 0.79 | ALDH1A1 (0.44) | KDM4EALDH1A1IDO1L3MBTL1KMT2A | |
| SCHEMBL9705001 | 0.79 | TRPA1 (0.47) | CTBP2IDO1TAAR1TRPA1KMT2A | |
| SCHEMBL10070249 | 0.79 | ESR1 (0.44) | ESR1ESR2ABATCA2KDM4E | |
| SCHEMBL9705002 | 0.79 | TRPA1 (0.47) | CTBP2IDO1TAAR1TRPA1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2486404-A1 | METABOLIC BIOMARKERS OF DRUG-INDUCED CARDIOTOXICITY | Wisconsin Alumni Research Foundation (US) | 2012-08-15 | — | — | EP | claimed |
| WO-2011044253-A1 | METABOLIC BIOMARKERS OF DRUG-INDUCED CARDIOTOXICITY | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-04-14 | — | — | WO | claimed |
| US-20110081675-A1 | Metabolic Biomarkers Of Drug-Induced Cardiotoxicity | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-04-07 | — | — | US | claimed |
| US-20180203018-A1 | METABOLIC BIOMARKERS OF CROHN'S DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-07-19 | — | — | US | disclosed |
| US-20150232889-A1 | Method of Producing a Low Molecular Weight Organic Compound in a Cell | EVOLVA SA (CH) | 2015-08-20 | — | — | US | disclosed |
| US-20120213772-A1 | Metabolic biomarkers of Crohn's Disease | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-08-23 | — | — | US | disclosed |
| EP-2486404-A1 | METABOLIC BIOMARKERS OF DRUG-INDUCED CARDIOTOXICITY | Wisconsin Alumni Research Foundation (US) | 2012-08-15 | — | — | EP | disclosed |
| WO-2011044253-A1 | METABOLIC BIOMARKERS OF DRUG-INDUCED CARDIOTOXICITY | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-04-14 | — | — | WO | disclosed |
| US-20110081675-A1 | Metabolic Biomarkers Of Drug-Induced Cardiotoxicity | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-04-07 | — | — | US | disclosed |
| WO-2011034397-A2 | METHOD FOR PREDICTING DRUG TARGETS AND SCREENING FOR DRUGS FOR PATHOGENIC MICROORGANISMS USING ESSENTIAL METABOLITES | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | disclosed |
| WO-2011009099-A1 | METABOLIC BIOMARKERS OF CROHN'S DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-01-20 | — | — | WO | disclosed |
| EP-1234046-A2 | UDP-GLUCOSE:AGLYCON-GLUCOSYLTRANSFERASE | LUMINIS PTY. LIMITED (AU) | 2002-08-28 | — | — | EP | disclosed |
| US-6300544-B1 | ISOLATED NUCLEIC ACIDS; CATALYZES THE CONVERSION OF AN ALDOXIME TO THE CORRESPONDING NITRILE AND THEN TO THE CYANOHYDRIN FOR BIOSYNTHESIS OF CYANOGLYCOSIDES; PEST RESISTANT TRANSGENIC PLANTS OR PLANTS WITH NUTRITIVE VALUE | SYNGENTA PARTICIPATIONS AG (CH) | 2001-10-09 | — | — | US | disclosed |
| WO-2001040491-A2 | UDP-GLUCOSE:AGLYCON-GLUCOSYLTRANSFERASE | LUMINIS PTY, LIMITED (AU) | 2001-06-07 | — | — | WO | disclosed |
| US-6133417-A | ENZYME CATALYZES CONVERSION OF AMINO ACID TO CORRESPONDING N-HYDROXYAMINO ACID AND THEN INTO CORRESPONDING OXIME; FOR TRANSGENIC PLANTS RESISTANT TO INSECTS, ACARIDS, OR NEMATODES OR PLANTS WITH IMPROVED NUTRITIVE VALUE | NOVARTIS FINANCE CORPORATION (US) | 2000-10-17 | — | — | US | disclosed |
| EP-0970191-A2 | CYTOCHROME P450 MONOOXYGENASES | Novartis AG (CH) | 2000-01-12 | — | — | EP | disclosed |
| US-5882851-A | DNA MOLECULE CODING FOR A CYTOCHROME P-450 MONOOXYGENASE THAT CATALYZES THE CONVERSION OF AN AMINO ACID TO THE CORRESPONDING N-HYDROXYAMINO ACID AND THE CONVERSION OF SAID N-HYDROXYAMINO ACID TO THE CORRESPONDING OXIME | NOVARTIS FINANCE CORPORATION (US) | 1999-03-16 | — | — | US | disclosed |
| WO-1998040470-A2 | CYTOCHROME P450 MONOOXYGENASES | NOVARTIS AG (CH) | 1998-09-17 | — | — | WO | disclosed |
| EP-0733112-A1 | CYTOCHROME P-450 MONOOXYGENASES | Novartis AG (CH) | 1996-09-25 | — | — | EP | disclosed |
| WO-1995016041-A1 | CYTOCHROME P-450 MONOOXYGENASES | CIBA-GEIGY AG (CH) | 1995-06-15 | — | — | WO | disclosed |